Ensign Peak Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.02M | Buy |
28,435
+4,316
| +18% | +$458K | 0.01% | 773 |
|
|
2025
Q1 | $2.99M | Sell |
24,119
-245
| -1% | -$30.4K | 0.01% | 769 |
|
|
2024
Q4 | $3M | Sell |
24,364
-1,883
| -7% | -$232K | 0.01% | 794 |
|
|
2024
Q3 | $2.92M | Sell |
26,247
-1,837
| -7% | -$205K | 0.01% | 792 |
|
|
2024
Q2 | $3M | Sell |
28,084
-1,245
| -4% | -$133K | 0.01% | 772 |
|
|
2024
Q1 | $3.53M | Sell |
29,329
-5,615
| -16% | -$676K | 0.01% | 743 |
|
|
2023
Q4 | $4.3M | Buy |
34,944
+3,615
| +12% | +$445K | 0.01% | 662 |
|
|
2023
Q3 | $4.06M | Buy |
31,329
+7,429
| +31% | +$962K | 0.01% | 628 |
|
|
2023
Q2 | $2.96M | Sell |
23,900
-3,740
| -14% | -$464K | 0.01% | 743 |
|
|
2023
Q1 | $4.04M | Buy |
27,640
+1,535
| +6% | +$225K | 0.01% | 628 |
|
|
2022
Q4 | $4.16M | Sell |
26,105
-430
| -2% | -$68.5K | 0.01% | 603 |
|
|
2022
Q3 | $3.54M | Sell |
26,535
-850
| -3% | -$113K | 0.01% | 618 |
|
|
2022
Q2 | $4.27M | Buy |
27,385
+3,975
| +17% | +$620K | 0.01% | 580 |
|
|
2022
Q1 | $3.64M | Sell |
23,410
-5,120
| -18% | -$797K | 0.01% | 676 |
|
|
2021
Q4 | $3.64M | Sell |
28,530
-76,190
| -73% | -$9.71M | 0.01% | 762 |
|
|
2021
Q3 | $13.6M | Sell |
104,720
-28,375
| -21% | -$3.69M | 0.03% | 374 |
|
|
2021
Q2 | $23.6M | Sell |
133,095
-3,145
| -2% | -$559K | 0.05% | 292 |
|
|
2021
Q1 | $22.4M | Sell |
136,240
-46,170
| -25% | -$7.59M | 0.05% | 293 |
|
|
2020
Q4 | $30.1M | Sell |
182,410
-85,340
| -32% | -$14.1M | 0.07% | 245 |
|
|
2020
Q3 | $38.2M | Buy |
267,750
+7,130
| +3% | +$1.02M | 0.1% | 175 |
|
|
2020
Q2 | $28.8M | Sell |
260,620
-49,430
| -16% | -$5.45M | 0.08% | 219 |
|
|
2020
Q1 | $30.9M | Buy |
310,050
+710
| +0.2% | +$70.8K | 0.1% | 146 |
|
|
2019
Q4 | $46.2M | Buy |
+309,340
| New | +$46.2M | 0.12% | 138 |
|